Pharmacologic Decision-making in the Treatment of Focal Epilepsy— A Critical Comparison of Antiepileptic Drugs
Epilepsy, antiepileptic drug, focal seizures, treatment decisions, enzyme inducers, effectiveness, cost
Digital Object Identifier (DOI)
Physicians who treat patients with epilepsy must balance many factors when selecting the appropriate treatment for an individual patient, including seizure type, concomitant antiepileptic drug (AED) therapy, age, comorbid conditions, and even insurance coverage. Optimal management of seizures is further complicated by a continuously increasing pool of AEDs. As seizure type is a main factor in AED selection, this review will provide an evidence-based guide for physicians treating focal epilepsy. This includes a summary of efficacy, safety, and tolerability data from randomized clinical trials as well as findings related to rational polypharmacy, drug–drug interactions, comorbidities, drug administration (titration, dosing, formulation), US Food and Drug Administration (FDA)-approved indications, and cost. Following the review are four case reports that provide real-life examples of clinical challenges physicians face, particularly when dealing with special populations, which highlight the decision-making process entailed when determining the best course of treatment for patients with epilepsy.
Was this content written or created while at USF?
Citation / Publisher Attribution
US Neurology, v. 10, issue 2, p. 92-103
Scholar Commons Citation
Benbadis, Selim R.; Stefan, Hermann; Morita, Diego; Abou-Khalil, Bassel; and Hogan, R. Edward, "Pharmacologic Decision-making in the Treatment of Focal Epilepsy— A Critical Comparison of Antiepileptic Drugs" (2014). Neurology Faculty Publications. 96.